Inhaled isoniazid for tuberculosis treatment
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests inhaled isoniazid (medicine) given through a nebulizer to see how well it works and how safe it is. It's for people being treated for tuberculosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with tuberculosis that can be treated with standard drugs.
- You have been on effective TB treatment for at least 2 weeks and your condition is stable or improving.
- You are not pregnant or breastfeeding.
- You have not had a bad reaction to isoniazid before.
- You do not take certain medicines like corticosteroids (unless on a stable low dose), antacids with aluminum, carbamazepine, phenytoin, or theophylline.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests different treatment plans for people with tuberculosis (TB) that can be cured with standard medicines. It aims to find the best treatment for each person based on their risk score, which may lead to shorter or more effective treatment.
This trial tests a new, all-oral, shorter treatment regimen for tuberculosis that is resistant to rifampicin, a key antibiotic. It may offer a more convenient and effective option for patients with this difficult-to-treat infection.
This study tests whether two medicines, metformin and N-acetylcysteine, can help your lungs heal better after tuberculosis (TB). You will receive one of these study drugs along with your regular TB treatment.
This study looks at how often isoniazid, a medicine used to treat tuberculosis, causes liver damage in everyday practice, and what factors might predict that risk. If you are taking or have taken isoniazid, this research may help doctors understand your risk and improve safety for other patients.
This trial tests a combination of drugs for people with active tuberculosis who have not been treated before. It aims to find a better way to treat TB, even if the bacteria are resistant to some drugs.
This Phase 2 study tests treatment for people with newly diagnosed, drug-susceptible pulmonary (lung) tuberculosis (TB). It aims to see whether the study treatment works well and is safe for curing TB.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.